Twist Bioscience Corp
For the period ended Feb 5, 2026. Filed Jan 6, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Feb 5, 2026 · Filed Jan 6, 2026
Use the contents to explore the available documents and sections.
Contents
Code of Conduct
We have adopted the Twist Bioscience Corporation Code of Business Conduct and Ethics (the “Code of
Ethics”) with which every person, including executive officers, who works for Twist and every member of our
Board is expected to comply. We require each of our employees and Board members to review and confirm
compliance with our Code of Ethics annually. The full text of our Code of Ethics is posted on the investor
relations section of our website at www.twistbioscience.com. If any substantive amendments are made to the
Code of Ethics or any waiver is granted, we intend to satisfy the disclosure requirement under Item 5.05 of
Form 8-K regarding such amendment to, or waiver from, a provision of this Code of Ethics by posting such
information on our website, at the address and location specified above, or as otherwise required by the
Nasdaq Select Global Market.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.